Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Angélique Brunot
Observed names:
A. Brunot,
Angelique Brunot,
Brunot, Angélique
Institution:
Centre Eugène Marquis
Observed institutions:
Inserm,
École des Hautes Études en Santé Publique,
Institut de Recherche en Santé, Environnement et Travail,
Centre Eugène Marquis,
Hôpital Pontchaillou,
Centre Hospitalier Universitaire de Rennes,
Université Rennes 1,
Université de Rennes
show all 8
OpenAlex ID:
A5028890871
Hepatocellular carcinoma in elderly patients: challenges and solutions
2016
·
Angélique Brunot
, Samuel LE SOURD
, et al.
·
Journal of Hepatocellular Carcinoma
·
60
PDF
Independent association of PD‐L1 expression with noninactivated VHL clear cell renal cell carcinoma—A finding with therapeutic potential
2016
·
Solène‐Florence Kammerer‐Jacquet
, Laurence Crouzet
, et al.
·
International Journal of Cancer
·
56
Single-cell Deconvolution of a Specific Malignant Cell Population as a Poor Prognostic Biomarker in Low-risk Clear Cell Renal Cell Carcinoma Patients
2023
·
Judikael R. Saout
, Gwendoline Lecuyer
, et al.
·
European Urology
·
45
PDF
Development of multiplex digital PCR assays for the detection of PIK3CA mutations in the plasma of metastatic breast cancer patients
2021
·
Julien Corné
, Fanny Le Du
, et al.
·
Scientific Reports
·
38
PDF
Synchronous Metastatic Clear-Cell Renal Cell Carcinoma: A Distinct Morphologic, Immunohistochemical, and Molecular Phenotype
2016
·
Solene-Florence Kammerer-Jacquet
, Angelique Brunot
, et al.
·
Clinical Genitourinary Cancer
·
37
Wild-type VHL Clear Cell Renal Cell Carcinomas Are a Distinct Clinical and Histologic Entity: A 10-Year Follow-up
2015
·
Julien Dagher
, Solène-Florence Kammerer-Jacquet
, et al.
·
European Urology Focus
·
37
Correlation of c-MET Expression with PD-L1 Expression in Metastatic Clear Cell Renal Cell Carcinoma Treated by Sunitinib First-Line Therapy
2017
·
Solène-Florence Kammerer-Jacquet
, Sarah Medane
, et al.
·
Targeted Oncology
·
31
Sorafenib use in elderly patients with hepatocellular carcinoma: caution about use of platelet aggregation inhibitors
2014
·
Julien Edeline
, Laurence Crouzet
, et al.
·
Cancer Chemotherapy and Pharmacology
·
25
Association of Anti–Programmed Cell Death 1 Antibody Treatment With Risk of Recurrence of Toxic Effects After Immune-Related Adverse Events of Ipilimumab in Patients With Metastatic Melanoma
2020
·
Angélique Brunot
, Jean-Jacques Grob
, et al.
·
JAMA Dermatology
·
23
PDF
Implementation of a Nurse-driven Educational Program Improves Management of Sorafenib’s Toxicities in Hepatocellular Carcinoma
2017
·
Angélique Brunot
, Florence Le Roy
, et al.
·
Cancer Nursing
·
20
Development of sensitive and robust multiplex digital PCR assays for the detection of ESR1 mutations in the plasma of metastatic breast cancer patients
2023
·
Julien Corné
, Véronique Quillien
, et al.
·
Clinica Chimica Acta
·
14
Plasma‐based analysis of ERBB2 mutational status by multiplex digital PCR in a large series of patients with metastatic breast cancer
2024
·
Julien Corné
, Véronique Quillien
, et al.
·
Molecular Oncology
·
8
PDF
Multiple metastatic clones assessed by an integrative multiomics strategy in clear cell renal carcinoma: a case study
2021
·
Julien Dagher
, Angelique Brunot
, et al.
·
Journal of Clinical Pathology
·
8
Regorafenib as maintenance therapy after first-line doxorubicin-based chemotherapy in advanced non-adipocytic soft tissue sarcomas patients: a double-blind randomised trial
2025
·
N. Penel
, A. Italiano
, et al.
·
Annals of Oncology
·
5
Impact of EPclin on adjuvant therapeutic decision making and comparison of EPclin to the PREDICT tool
2021
·
Héloïse Bourien
, Véronique Quillien
, et al.
·
The International Journal of Biological Markers
·
5
Therapeutic innovations in breast cancer
2019
·
Fanny Le Du
, Christophe Perrin
, et al.
·
La Presse Médicale
·
5
PDF
Metastatic Clear-cell Renal Cell Carcinoma With a Long-term Response to Sunitinib: A Distinct Phenotype Independently Associated With Low PD-L1 Expression
2019
·
Solène-Florence Kammerer-Jacquet
, Angelique Brunot
, et al.
·
Clinical Genitourinary Cancer
·
5
PDF
Anti-PD-1 tolerance after severe toxicity with ipilimumab therapy in metastatic melanoma patients.
2016
·
Angelique Brunot
, Geraldine Jeudy
, et al.
·
Journal of Clinical Oncology
·
5
Les infirmières cliniciennes améliorent la gestion des toxicités des patients traités par sorafénib pour carcinome hépatocellulaire
2016
·
Angélique Brunot
, Amel M'Sadek
, et al.
·
Bulletin du Cancer
·
4
1524MO Patterns of care and outcomes of 64 CIC-rearranged sarcoma: A retrospective multicentre case-series within the French Sarcoma Group (FSG)
2021
·
B. Mehdi
, N. Gaspar
, et al.
·
Annals of Oncology
·
3
PDF
PDL-1 and PDL1 expressions in clear cell renal cell carcinoma (ccRCC) of metastatic patients with sunitinib first-line treatment.
2015
·
Angélique Brunot
, Jean-Christophe Bernhard
, et al.
·
Journal of Clinical Oncology
·
3
1718O EREMISS trial: A double-blind placebo (PBO)-controlled randomised trial assessing efficacy/safety of regorafenib (REGO) as maintenance therapy after 1st line doxorubicin-based chemotherapy in advanced soft-tissue sarcoma (ASTS) patients (pts)
2024
·
N. Penel
, A. Italiano
, et al.
·
Annals of Oncology
·
2
PDF
Hilar fat infiltration: A new prognostic factor in metastatic clear cell renal cell carcinoma with first-line sunitinib treatment
2017
·
Solène-Florence Kammerer-Jacquet
, Angelique Brunot
, et al.
·
Urologic Oncology Seminars and Original Investigations
·
2
58P Detection of PIK3CA mutations in plasma ctDNA by Crystal Digital PCR for the selection of alpelisib treatment in routine clinical practice in advanced breast cancer patients
2020
·
T. de La Motte Rouge
, F. Le Du
, et al.
·
Annals of Oncology
·
1
1865 Activity and toxicity profile of eribulin mesylate in heavily pretreated metastatic breast cancer: An observational study (EVHALAVEN)
2015
·
A. Patsouris
, A.L. Septans
, et al.
·
European Journal of Cancer
·
1
Show more works
View as search
Works count:
44
Citation count:
445
H-index:
11
I10-index:
11
Year
Topic
Type